Skip to content

Classification of the baby who was born with low weight in Undernutrition or Preterm birth according to the response of his skin to light, a validation for the Preemie-Test

Prematurity or Intrauterine Malnutrition? Clinical Trial for classification of the low-weight newborn through the optical properties of the skin, a validation for the Preemie-Test

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-33rnjf
Enrollment
Unknown
Registered
2018-07-09
Start date
2019-02-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Slow fetal growth and fetal malnutrition. Premature Birth. Hyaline Membrane Disease. Transient Tachypnea of the Newborn.

Interventions

Experimental group, single arm: 298 newborns with low birth weight, lower than 2500 grams, assessed during the first 24 hours of life with a prototype of a non invasive medical device which measures t
Device

Sponsors

Faculdade de Medicina da Universidade Federal de Minas Gerais
Lead Sponsor
Fundação Oswaldo Cruz
Collaborator

Eligibility

Age
0 Hours to 24 Hours

Inclusion criteria

Inclusion criteria: Alive newborn. Be until the first 24 hours of life. Be equal or more than 24 weeks of gestational age at birth. Birthweight less than 2500 grams. Fetal had an obstetric ultrasound assessment before 24 weeks of pregnancy or pregnant women had trustable last menstrual period. Regarding the nested control case study be newborn with diagnosing of neonatal respiratory distress syndrome or transient tachypnea assessed until 72 hours after birth. Controls will be randomly paired by ranges of gestational age.

Exclusion criteria

Exclusion criteria: Be malformatted with a compromise of the structure of the skin. Has anhydramnios or fetal hydrops or genodermatoses or chorioamnionitis. In the nested case-control study present extrapulmonary conditions with tachypnea not due to prematurity.

Design outcomes

Primary

MeasureTime frame
Primary outcome 1: The difference between the gestational age at birth, calculated by the photobiological neonatal skin assessment methodology in relation to the age calculated by the comparators. Data availability statement: the authors plan to share the minimal deidentified data set necessary to replicate study findings. The coordinator of the clinical trial will provide data access under reasonable request since the original study citation is warranted.;Primary outcome 2: Proportion of the preterm newborn correctly detected at birth, based on the photobiological test of his skin, within one week error in relation to the comparators.

Secondary

MeasureTime frame
Secondary outcome 1: Proportion of the small-for-gestational-age newborn correctly detected, based on the photobiological test of the skin and the fetal growth standard of the Intergrowth 21st Group, in relation to the comparators.;Secondary outcome 2: To describe the relationship between the skin reflectance measurement of the newborn with the respiratory distress syndrome, with diagnosis based on clinical and radiological findings, during the first seventy two hours of life.;Secondary outcome 3: To describe the relationship between the skin reflectance measurement of the newborn with the transient tachypnea of the newborn, with diagnosis based on clinical findings, during the first seventy two hours of life.;Secondary outcome 4: To describe the relationship between the skin reflectance measurement of the newborn with a ventilatory support need due to pulmonary immaturity, during the first seventy two hours of life. ;Secondary outcome 5: To describe the relationship between the skin reflectance measurement of the newborn with neonatal care intensive unit admission needs, during the first seventy two hours of life, due to pulmonary immaturity.

Countries

Brazil, Mozambique

Contacts

Public ContactZilma Reis

Faculdade de Medicina da Universidade Federal de Minas Gerais

zilma.medicina@gmail.com5531985177473

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 18, 2026